Latest Commercialization News

Rewardle Holdings reported a strong March quarter with positive operational cash flow of $1.36 million, driven by its strategic partnership with MedTech firm CloudHolter, while progressing towards ASX relisting.

Solstice Minerals has initiated a significant Reverse Circulation drilling campaign targeting advanced gold prospects in Western Australia, aiming to expand on promising historical intercepts and recent exploration success.

Dimerix has inked an exclusive US licensing agreement with Amicus Therapeutics for DMX-200, a promising Phase 3 treatment for FSGS, unlocking $30 million upfront and up to $560 million in milestones.

Imricor Medical Systems has initiated its first MRI-guided atrial flutter ablation procedures at Semmelweis University in Budapest, marking a significant expansion of its real-time MRI technology in Europe.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Everest Metals has secured a $50,000 CSIRO Kick-Start voucher to conduct advanced geochemical studies on rubidium, lithium, and caesium at its Mt Edon project, aiming to enhance recovery processes and exploration targeting over nine months.

Tempest Minerals Ltd has announced a maiden inferred resource estimate of 63.5 million tonnes at 30.6% iron for its Remorse Magnetite Iron Deposit, marking a pivotal step from exploration to development at the Yalgoo Project.

Zimi Limited confirms $1.42 million in open orders with key distributor GSM Electrical, backed by shareholder approval for up to $6 million in future sales. The company also advances its commercial market ambitions through a new partnership with Zencontrol.

Spenda Limited reported a robust Q3 FY25 with cash receipts soaring 160% year-on-year despite a strategic sale of its invoice finance loan book. The company secured a $3 million loan facility and forecasts a record-breaking quarter ahead.

Memphasys Limited has completed a pivotal Phase III trial confirming its Felix™ System as best-in-class for sperm separation, while advancing regulatory and commercial efforts in China and Brazil supported by fresh capital.

PARKD Limited has secured a pivotal 5-year exclusive licence with Fielders for its metal deck support IP, completed a major car storage facility, and reported positive operating cash flow in Q3 FY25, positioning the company for expanded commercial growth.

Earth’s Energy Limited reports progress on South Australian geothermal projects with promising feasibility study results, while navigating executive transitions and shareholder governance challenges.